Bioactive constituents from three Vismia species

Area of Science:

• Natural Product Chemistry
• Pharmacology
• Medicinal Chemistry

Background:

• Vismia species are known sources of bioactive compounds.
• Natural products are a vital resource for anticancer drug discovery.
• Previous research has indicated the potential of Vismia extracts in cancer treatment.

Purpose of the Study:

• To isolate and identify bioactive compounds from Vismia baccifera, V. jefensis, and V. macrophylla.
• To evaluate the cytotoxic activity of isolated compounds against human breast, CNS, and lung cancer cell lines.
• To discover novel anticancer agents from these plant species.

Main Methods:

• Bioassay-guided fractionation of methanolic plant extracts.
• Isolation and structural elucidation of compounds using spectroscopic methods.
• In vitro cytotoxic assays against human cancer cell lines.

Main Results:

• A new compound, ferruginin C (1), was isolated along with seven known compounds (2-8).
• Compounds 6-8 (vismione B, deacetylvismione H, deacetylvismione A) exhibited the highest cytotoxic activity.
• The cytotoxic activity of ferruginins A and B (2, 3), vismin (4), harunganin (5), and deacetylvismione H (7) was reported for the first time.

Conclusions:

• Vismia species contain compounds with significant cytotoxic activity against various cancer cell lines.
• Ferruginin C represents a novel compound with potential anticancer properties.
• Compounds vismione B, deacetylvismione H, and deacetylvismione A are potent cytotoxic agents warranting further investigation.